LMT vs BA vs GD
161 measures in 16 categories, one definition each, computed from filings and market data.
LMT68.4
Lockheed Martin Corporation
Industrials · Aerospace & Defense
$552.09 +3.62%$127.4B mkt cap
Score DNA
GD66.1
General Dynamics Corporation
Industrials · Aerospace & Defense
$344.23 +2.12%$93.1B mkt cap
Score DNA
Price, rebased to 100 three years ago
LMT BA GD · weekly adjusted closesSmart money 8Valuation 16Profitability (TTM) 12Returns on capital 11Growth 17Margin history & stability 7Liquidity (latest quarter) 7Leverage & solvency (latest quarter) 13Efficiency 11Cash flow & earnings quality 7Dividends & buybacks 9Scores & forensic checks 15Per share 7Size (TTM) 8Price performance 9Technicals 4
● marks the highest or lowest value where that direction is plainly stronger (margins, returns, coverage, leverage); multiples and yields are left unmarked. Bars show each stock's percentile within its own industry. n/a: the measure does not apply to lenders and insurers.
Smart money
8 measures| Measure | LMT | BA | GD |
|---|---|---|---|
| Insider open-market buys, 180d | 0 | 1 | 0 |
| Insider $ bought, 180d | — | $0.30M | — |
| Congress purchases, 180d | 1 | 0 | 0 |
| Last Congress purchase | 2026-03-27 | — | — |
| 13F net change in holders | −141 | +108 | −2 |
| ETFs adding shares, 30d | 992 | 956 | 962 |
| ETFs trimming, 30d | 756 | 704 | 710 |
| Net ETF funds, 30d | +236 | +252 | +252 |
Valuation
16 measures| Measure | LMT | BA | GD |
|---|---|---|---|
| P/E (TTM) | 20.3x
8th
|
61.7x
87th
|
20.8x
15th
|
| PEG (P/E ÷ 3-yr EPS CAGR) | — | — | 2.03
67th
|
| Price / sales | 1.7x
20th
|
1.6x
16th
|
1.7x
22nd
|
| Price / book | 14.5x
87th
|
24.6x
96th
|
3.5x
47th
|
| Price / tangible book | — | — | 22.1x
68th
|
| Price / free cash flow | 14.6x
17th
|
— | 14.4x
11th
|
| Price / operating cash flow | 12.2x
15th
|
41.3x
82nd
|
12.1x
13th
|
| Enterprise value | $144.2B
95th
|
$176.2B
96th
|
$98.3B
93rd
|
| EV / sales | 1.9x
18th
|
1.9x
20th
|
1.8x
16th
|
| EV / EBITDA | 14.1x
26th
|
23.4x
64th
|
15.3x
29th
|
| EV / EBIT | 16.8x
21st
|
32.9x
69th
|
17.1x
23rd
|
| EV / free cash flow | 16.5x
14th
|
— | 15.2x
11th
|
| Earnings yield | 4.9%
95th
|
1.6%
38th
|
4.8%
89th
|
| FCF yield | 6.9%
89th
|
-0.1%
31st
|
6.9%
93rd
|
| Operating cash flow yield | 8.2%
89th
|
2.4%
42nd
|
8.3%
91st
|
| Graham number (per share) | $152.39
84th
|
$23.11
39th
|
$190.07
95th
|
Profitability (TTM)
12 measures| Measure | LMT | BA | GD |
|---|---|---|---|
| Gross margin | 11.8%
11th
|
4.7%
2nd
|
15.4%
19th
|
| EBITDA margin | 13.3%
58th
|
8.0%
34th
|
11.7%
45th
|
| Operating margin | 11.9%
75th
|
-5.4%
19th
|
10.3%
58th
|
| EBIT margin | 11.1%
60th
|
5.7%
34th
|
10.5%
57th
|
| Net margin | 8.2%
60th
|
2.6%
34th
|
8.2%
64th
|
| NOPAT margin | 10.1%
72nd
|
-5.0%
19th
|
8.5%
62nd
|
| FCF margin | 11.3%
74th
|
-0.2%
28th
|
11.8%
77th
|
| Operating cash flow margin | 13.5%
70th
|
3.9%
38th
|
14.0%
74th
|
| R&D / revenue | 0.9%
40th
|
3.9%
71st
|
0.9%
42nd
|
| SG&A / revenue | 0.0%
0th
|
6.2%
19th
|
5.0%
17th
|
| Stock comp / revenue | 0.4%
24th
|
0.4%
19th
|
0.4%
20th
|
| Effective tax rate | 15.3%
20th
|
7.5%
4th
|
17.6%
35th
|
Returns on capital
11 measures| Measure | LMT | BA | GD |
|---|---|---|---|
| ROE (on average equity) | 89.2%
94th
|
173.6%
96th
|
17.8%
71st
|
| ROA | 10.4%
91st
|
1.5%
31st
|
7.7%
67th
|
| ROIC | 30.4%
96th
|
-14.7%
16th
|
14.6%
76th
|
| ROCE | 22.2%
98th
|
9.5%
56th
|
13.9%
76th
|
| Return on tangible assets | 14.1%
91st
|
3.3%
35th
|
9.8%
67th
|
| Cash ROIC (OCF / invested capital) | 40.8%
96th
|
11.4%
59th
|
24.1%
87th
|
| Gross profitability (GP / assets) | 14.5%
49th
|
2.7%
9th
|
14.0%
45th
|
| ROIC, 3-yr average | 28.3%
100th
|
-20.0%
3rd
|
11.5%
82nd
|
| ROIC, 5-yr average | 31.7%
98th
|
— | 12.3%
71st
|
| ROE, 5-yr average | 75.4%
98th
|
— | 17.3%
85th
|
| Incremental ROIC | 179.6%
92nd
|
264.2%
96th
|
61.7%
70th
|
Growth
17 measures| Measure | LMT | BA | GD |
|---|---|---|---|
| Revenue growth (TTM YoY) | 7.2%
10th
|
24.8%
63rd
|
9.1%
20th
|
| Revenue growth (QoQ) | 11.3%
56th
|
10.5%
55th
|
4.5%
27th
|
| Revenue CAGR, 3 yr | 4.6%
15th
|
8.5%
28th
|
10.3%
37th
|
| Revenue CAGR, 5 yr | 2.9%
12th
|
8.8%
40th
|
7.3%
26th
|
| Gross profit CAGR, 3 yr | 2.0%
14th
|
-3.2%
7th
|
8.6%
31st
|
| Operating income CAGR, 3 yr | 2.0%
18th
|
— | 10.3%
29th
|
| Net income growth (TTM YoY) | 49.5%
58th
|
— | 9.8%
17th
|
| Net income CAGR, 3 yr | -3.8%
10th
|
— | 10.0%
33rd
|
| EPS growth (TTM YoY) | 51.6%
64th
|
— | 8.7%
17th
|
| EPS CAGR, 3 yr | -0.8%
17th
|
— | 10.2%
37th
|
| EPS CAGR, 5 yr | 1.2%
23rd
|
— | 7.1%
38th
|
| FCF growth (TTM YoY) | 162.2%
81st
|
— | 56.1%
65th
|
| FCF CAGR, 3 yr | 13.3%
27th
|
— | 28.7%
64th
|
| Operating cash flow CAGR, 3 yr | 10.4%
24th
|
-26.6%
0th
|
23.0%
52nd
|
| Book value CAGR, 3 yr | 1.4%
30th
|
— | 11.4%
59th
|
| Dividend CAGR, 3 yr | 4.0%
62nd
|
18.7%
97th
|
1.8%
34th
|
| Sustainable growth rate | 44.1%
92nd
|
149.0%
100th
|
11.3%
47th
|
Margin history & stability
7 measures| Measure | LMT | BA | GD |
|---|---|---|---|
| Gross margin, 3-yr average | 10.7%
7th
|
4.6%
0th
|
15.5%
17th
|
| Operating margin, 3-yr average | 10.7%
67th
|
-6.7%
15th
|
10.2%
63rd
|
| Net margin, 3-yr average | 7.8%
63rd
|
-5.4%
15th
|
8.1%
65th
|
| FCF margin, 3-yr average | 8.6%
67th
|
-6.4%
20th
|
8.3%
65th
|
| Revenue stability (0-1) | 0.84
38th
|
0.81
29th
|
0.92
56th
|
| Earnings stability (0-1) | 0.07
4th
|
0.23
19th
|
0.85
81st
|
| Margin stability (0-1) | 0.83
38th
|
0.33
13th
|
0.96
81st
|
Liquidity (latest quarter)
7 measures| Measure | LMT | BA | GD |
|---|---|---|---|
| Cash & short-term investments | $3.8B
93rd
|
$20.0B
100th
|
$4.3B
95th
|
| Net cash (− = net debt) | −$16.7B
5th
|
−$25.9B
4th
|
−$5.1B
13th
|
| Working capital | $4.6B
95th
|
$15.1B
100th
|
$8.3B
98th
|
| Current ratio | 1.19
11th
|
1.14
5th
|
1.44
18th
|
| Quick ratio | 1.01
18th
|
0.33
0th
|
0.96
13th
|
| Cash ratio (cash + ST investments / current liabilities) | 0.16
13th
|
0.18
20th
|
0.23
31st
|
| Defensive interval (days) | — | 1,280 days
74th
|
2,105 days
87th
|
Leverage & solvency (latest quarter)
13 measures| Measure | LMT | BA | GD |
|---|---|---|---|
| Total debt | $20.5B
95th
|
$45.9B
100th
|
$9.5B
87th
|
| Debt / equity | 2.34
91st
|
7.52
96th
|
0.35
36th
|
| Net debt / equity | 1.91
92nd
|
4.24
96th
|
0.19
42nd
|
| Debt / assets | 32.9%
71st
|
27.7%
62nd
|
15.8%
33rd
|
| Debt / capital | 70.1%
91st
|
88.3%
96th
|
26.1%
36th
|
| Debt / EBITDA | 2.00
43rd
|
6.08
93rd
|
1.47
21st
|
| Net debt / EBITDA | 1.63
43rd
|
3.43
81st
|
0.80
29th
|
| Interest coverage (EBIT / interest) | 7.7x
65th
|
2.1x
25th
|
22.5x
94th
|
| Cash interest coverage | 9.4x
73rd
|
1.4x
29th
|
30.2x
96th
|
| Debt payback (years of OCF) | 2.0 yrs
28th
|
12.6 yrs
90th
|
1.2 yrs
21st
|
| Liabilities / assets | 86.0%
89th
|
96.3%
96th
|
55.4%
56th
|
| IS credit model rating | A | B- | AA+ |
| Implied credit spread (bps) | 150
35th
|
900
93rd
|
65
5th
|
Efficiency
11 measures| Measure | LMT | BA | GD |
|---|---|---|---|
| Asset turnover | 1.27
95th
|
0.59
49th
|
0.94
78th
|
| Fixed asset turnover | 6.76
70th
|
5.76
57th
|
7.24
74th
|
| Inventory turnover | 16.8
82nd
|
1.0
0th
|
4.9
60th
|
| Receivables turnover | 7.1
61st
|
28.0
100th
|
18.3
98th
|
| Days sales outstanding | 51 days
40th
|
13 days
2nd
|
20 days
4th
|
| Days inventory outstanding | 22 days
18th
|
359 days
100th
|
75 days
40th
|
| Days payables outstanding | 23 days
2nd
|
52 days
71st
|
23 days
9th
|
| Cash conversion cycle (days) | 50 days
33rd
|
320 days
98th
|
71 days
38th
|
| Capex / revenue | 2.2%
23rd
|
4.1%
58th
|
2.3%
26th
|
| Capex / depreciation | 0.99
43rd
|
1.75
72nd
|
1.80
74th
|
| Operating expense ratio | — | 9.5%
23rd
|
5.1%
2nd
|
Cash flow & earnings quality
7 measures| Measure | LMT | BA | GD |
|---|---|---|---|
| Operating cash flow / net income | 1.65
74th
|
1.49
64th
|
1.72
79th
|
| FCF / net income | 1.39
74th
|
−0.09
13th
|
1.44
79th
|
| FCF / operating cash flow | 83.9%
68th
|
-5.8%
3rd
|
83.7%
66th
|
| Capex / operating cash flow | 16.1%
32nd
|
105.8%
97th
|
16.3%
34th
|
| Accruals ratio | -6.8%
16th
|
-0.8%
64th
|
-5.5%
25th
|
| Sloan accruals ratio | 5.4%
69th
|
-6.9%
18th
|
1.5%
64th
|
| Earnings quality score (0-1) | 0.75
23rd
|
1.00
49th
|
0.75
23rd
|
Scores & forensic checks
15 measures| Measure | LMT | BA | GD |
|---|---|---|---|
| IS score | 68
84th
|
43
33rd
|
66
80th
|
| IS profitability | 49
73rd
|
25
42nd
|
39
64th
|
| IS growth | 72
59th
|
97
100th
|
54
24th
|
| IS value | 46
62nd
|
32
15th
|
52
85th
|
| IS momentum | 89
69th
|
100
96th
|
81
53rd
|
| IS risk (safety) | 80
29th
|
30
7th
|
100
44th
|
| IS quality | 67
56th
|
45
27th
|
77
91st
|
| IS balance sheet | 42
29th
|
34
18th
|
71
75th
|
| IS earnings quality | 82
95th
|
84
100th
|
68
55th
|
| IS cash flow | 71
82nd
|
35
40th
|
75
93rd
|
| Piotroski F-score (0-9) | 9
100th
|
6
31st
|
8
84th
|
| Altman Z-score | 3.4
35th
|
1.6
9th
|
4.3
45th
|
| Beneish M-score | −3.70
4th
|
−2.16
72nd
|
−2.78
22nd
|
| Ohlson O-score | −6.99
65th
|
−6.69
73rd
|
−8.85
22nd
|
| IS credit score | 74
65th
|
22
4th
|
92
89th
|
Size (TTM)
8 measures| Measure | LMT | BA | GD |
|---|---|---|---|
| Market cap | $127.4B
95th
|
$150.3B
96th
|
$93.1B
93rd
|
| Revenue | $77.0B
96th
|
$94.0B
100th
|
$54.9B
95th
|
| EBITDA | $10.3B
96th
|
$7.5B
95th
|
$6.4B
91st
|
| Net income | $6.3B
96th
|
$2.4B
91st
|
$4.5B
93rd
|
| Free cash flow | $8.7B
98th
|
−$210.0M
16th
|
$6.4B
95th
|
| Total assets | $62.5B
95th
|
$165.9B
98th
|
$60.2B
93rd
|
| Shareholders' equity | $8.8B
91st
|
$6.1B
87th
|
$26.8B
98th
|
| Employees | 123,000
96th
|
182,000
100th
|
117,000
95th
|
Price performance
9 measures| Measure | LMT | BA | GD |
|---|---|---|---|
| 1 day | +3.6% | +0.7% | +2.1% |
| 1 week | +8.3% | −0.2% | +3.9% |
| 1 month | +2.6% | −3.5% | −3.3% |
| 3 months | +8.3% | −9.3% | −7.1% |
| 6 months | −6.8% | −14.9% | +2.4% |
| Year to date | +11.6% | −16.6% | +0.6% |
| 1 year | +11.4% | −11.2% | +3.7% |
| 3 years, cumulative | +34.5% | −3.1% | +50.7% |
| 5 years, cumulative | +75.2% | −16.1% | +85.5% |
Technicals
4 measures| Measure | LMT | BA | GD |
|---|---|---|---|
| RSI 14 | 64.8 | 43.3 | 53.1 |
| From 52-week high | −20.2% | −25.3% | −13.9% |
| From 52-week low | +26.2% | +7.5% | +12.2% |
| Beta | 0.10 | 1.26 | 0.33 |
InsiderStreet reports findings from filings and market data. A comparison is not a recommendation to buy or sell either stock.Every figure is computed in code · data as of 2026-10-17